產(chǎn)品詳情
簡單介紹:
BAY43-9006
詳情介紹:
Characteristics | BAY 43-9006 is a novel bi-aryl urea compound that inhibits cell proliferation by targeting the ERK pathway and angiogenesis by targeting the receptor tyrosine kinases VEGFR-2 and PDGFR-beta and their associated signaling cascades. |
Purity | ≥ 99?% |
Formula | C??H??ClF?N?O?.C?H?O?S |
Permeability | Cell-permeable |
Molecular Weight | 637.03 g/mol |
CAS-No | 475207-59-1 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from light and moisture |
Storage | -20 °C |
Expiry Date | 24 months |
Supplier Images |
|
Product cited in: |
Lee, Lee, Kim, Kim: "Arabidopsis putative MAP kinase kinase kinases Raf10 and Raf11 are positive regulators of seed dormancy and ABA response." in: Plant & cell physiology, Vol. 56, Issue 1, pp. 84-97, 2015 (PubMed).
Chen, Chen, Wang, Tsai, Chen, Liou, Pan, Teng: "Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 20, Issue 5, pp. 1274-87, 2014 (PubMed). |